PNPLA3 and metabolic dysfunction-associated steatohepatitis: So far, for NASH, a plethora of biomarkers and predictive models and scores have been proposed for the early diagnosis or the prediction of fibrosis, some of these even including single nucleotide polymorphisms of the PNPLA3 gene [5].